Doctor Stuart A. Merl, MD is an expert in the field of Oncology. He researched medicine at Medical College of Pennsylvania and Hospital. Stuart Merl is a published doctor. He published 1 publication, including: 'A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group study (S0331).' Stuart Merl accepts Medicare payments and is listed with Medicare.gov.
NPI NUMBER | 1215927520 | |
NPPES Provider LastName | MERL | |
NPPES Provider FirstName | STUART | |
NPPES Provider ZIPCode | 454291264 | |
NPPES Provider State | OH | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 687.0 | |
Distinct Opioid Count | 4.0 | |
Opioid Claim Count | 60.0 | |
Percent Opioid Claims | 8.73 |
National Provider Identifier [NPI] | 1215927520 |
Last Name Of The Provider | MERL |
First Name Of The Provider | STUART |
View All |
![]() |
Dr. Alejandro R. Calvo, MD
![]() |
![]() |
Dr. Mark A. Marinella, MD
![]() ![]() |
![]() |
Dr. Burhan S. Yanes, MD
![]() ![]() |